Skip to content

Emblem™ S-Icd A209

by Boston Scientific

Emblem™ S-Icd A209 is a Class III device made by Boston Scientific, approved under FDA PMA P110042 on 28 Sep 2012 and listed in FDA GUDID since 26 May 2015 (UDI-DI 00802526544101), active as of 22 Oct 2026. 9 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

4 ongoing

This device is named in the recall

Documents

PMA P110042

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00802526544101 UDI-DI Date26 May 2015ListedStatusListed GUDID: in commercial distribution
United StatesFDA PMAAPPR from GUDID Approved NumberP110042 Date28 Sep 2012DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA PMA P110042 decided 28 Sep 2012 Active
  • FDA GUDID UDI-DI 00802526544101 listed 26 May 2015 Listed

Recalls

11 recalls · 4 ongoing · FDA

  • 2 recalls, same reason

    • Ongoing Z-2441-2023 FDA Class II initiated 11 Jul 2023
    • Ongoing Z-2442-2023 FDA Class II initiated 11 Jul 2023

    There is a potential for a rare interaction between the EMBLEM S-ICD and LATITUDE communicator, which may cause S-ICD sensing disablement for a 24-hour interval.

  • 2 recalls, same reason

    • Ongoing Z-0151-2023 FDA Class II initiated 30 Sep 2022 on shared PMA P110042
    • Ongoing Z-0152-2023 FDA Class II initiated 30 Sep 2022 on shared PMA P110042

    There is an incorrect manufacturing date/timestamp within the software which causes an inaccurate display of battery capacity.

    • Terminated Z-0474-2019 FDA Class II initiated 1 Nov 2018

    Experienced accelerated battery depletion and a shortened replacement interval due to latent internal battery malfunctions.

  • 3 recalls, same reason

    • Terminated Z-3038-2017 FDA Class II initiated 29 Jun 2017
    • Terminated Z-3037-2017 FDA Class II initiated 29 Jun 2017
    • Terminated Z-3039-2017 FDA Class II initiated 29 Jun 2017

    The device can deliver an atypical amount of energy due to memory corruption inside the device.

    • Terminated Z-1178-2017 FDA Class II initiated 12 Jan 2017

    There is a potential for radio frequency (RF) interference to alter wireless communication from a programmer, which in rare instances may cause an S-ICD to perform an unintended command. This behavior can only occur during an active, in-clinic interrogation/programming session with the Model 3200 S-ICD programmer. There is no risk of this behavior occurring when the LATITUDE Patient Management System communicates with an S-ICD in an ambulatory setting.

    • Terminated Z-0232-2016 FDA Class II initiated 17 Sep 2015

    Devices shipped to US in dual-channel rather than US approved single-channel RF Telemetry communication mode. While this does not impact therapy delivery of device; this can impact likelihood of successfully establishing telemetry during first scan of device when using a single-channel programmer. Telemetry can be established with additional scans; once established no further difficulty is expecte

    • Terminated Z-0965-2013 FDA Class II initiated 1 Mar 2013

    An internal protective fuse can be unintentionally activated while the device is charging its capacitors for shock delivery or induction. Should this occur, the defibrillator would not be able to deliver therapy or communicate with the Q-TECH Model 2020 programmer, and would be unable to emit tones or otherwise respond to magnet application.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Timeline

13 dated events

  1. Recall initiated FDA recalls Z-0232-2016
  2. Recall initiated FDA recalls Z-1178-2017
  3. Recall initiated FDA recalls Z-3038-2017
  4. Recall initiated FDA recalls Z-3037-2017
  5. Recall initiated FDA recalls Z-3039-2017
  6. Recall initiated FDA recalls Z-0474-2019
  7. Recall initiated FDA recalls Z-0151-2023
  8. Recall initiated FDA recalls Z-0152-2023
  9. Recall initiated FDA recalls Z-2441-2023
  10. Recall initiated FDA recalls Z-2442-2023

3 earlier events are in the sections above.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

GUDID

Trade name
Emblem™ S-Icd
Generic name
Single-chamber implantable defibrillator
Model / reference
A209
Primary DI / UDI-DI
00802526544101
PMA number
FDA product code
LWS
GMDN term
Single-chamber implantable defibrillator
Device class
Class III
GUDID distribution status
In Commercial Distribution
MRI safety
MR Conditional

Similar devices

Other devices filed under FDA product code LWS (Implantable cardioverter defibrillator (non-CRT)).

Other devices from Boston Scientific

See all devices from Boston Scientific →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Serial number
  • Expiration date
Other properties (9, all answered No)